LY3202626
Modify Date: 2024-10-03 10:12:19
LY3202626 structure
|
Common Name | LY3202626 | ||
|---|---|---|---|---|
| CAS Number | 1628690-73-2 | Molecular Weight | 498.508 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C22H20F2N8O2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LY3202626LY3202626 is a small molecule non-selective BACE1 inhibitor, causes dose-dependent reductions in CSF and plasma Aβ concentrations, shows potential for the treatment of Alzheimer's disease. Alzheimer Disease Phase 2 Clinical |
| Name | N-{3-[(4aR,7aS)-2-Amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl}-5-methoxy-2-pyrazinecarboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | LY3202626 is a small molecule non-selective BACE1 inhibitor, causes dose-dependent reductions in CSF and plasma Aβ concentrations, shows potential for the treatment of Alzheimer's disease. Alzheimer Disease Phase 2 Clinical |
|---|---|
| References | References View Related Products by Target Beta-secretase (BACE) Alzheimer Disease |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Molecular Formula | C22H20F2N8O2S |
| Molecular Weight | 498.508 |
| Exact Mass | 498.139801 |
| LogP | 3.08 |
| Index of Refraction | 1.750 |
| 2-Pyrazinecarboxamide, N-[3-[(4aR,7aS)-2-amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl]-5-methoxy- |
| N-{3-[(4aR,7aS)-2-Amino-6-(5-fluoro-2-pyrimidinyl)-4a,5,6,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a(4H)-yl]-4-fluorophenyl}-5-methoxy-2-pyrazinecarboxamide |